A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis

Pioglitazone is used effectively to treat non-alcoholic steatohepatitis (NASH), but there is marked variability in response. This study examined whether genetic variation contributes to pioglitazone response variability in patients with NASH. This genetic substudy includes 55 participants of a rando...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Pharmacol
Päätekijät: Kawaguchi-Suzuki, Marina, Cusi, Kenneth, Bril, Fernando, Gong, Yan, Langaee, Taimour, Frye, Reginald F.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2018
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6056641/
https://ncbi.nlm.nih.gov/pubmed/30065651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00752
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia